|Drug Patent Number||Company||Drug Patent Title||Drug Patent Expiry||Activity Alert|
|These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US6806256||JANSSEN PHARMS||Taste masked liquid pharmaceutical compositions|| |
(1 year, 7 months ago)
|JANSSEN PHARMS||Taste masked liquid pharmaceutical compositions|| |
(1 year, 1 month ago)
Levaquin is owned by Janssen Pharms.
Levaquin contains Levofloxacin.
Levaquin has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Levaquin are:
Levaquin was authorised for market use on 21 October, 2004.
Levaquin is available in solution;oral dosage forms.
The generics of Levaquin are possible to be released after 26 August, 2022.
Market Authorisation Date: 21 October, 2004
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic